Amgen SVP granted RSUs and stock options
Amgen Inc. senior vice president Rachna Khosla reported routine equity compensation changes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amgen Inc. senior vice president Rachna Khosla reported routine equity compensation changes. On May 5, 2026, she received an award of 500 shares of common stock at $0.00 per share and a grant of 3,266 non-qualified stock options with a $329.59 exercise price, all under Amgen’s Equity Incentive Plan. The options and related Restricted Stock Units vest in four equal annual installments of 25% each, beginning on May 5, 2027. On May 6, 2026, 79 shares of common stock at $329.59 were withheld to cover tax obligations. After these transactions, she directly holds 8,487 shares of Amgen common stock.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Khosla Rachna
Role
SVP, Business Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 79 | $329.59 | $26K |
| Grant/Award | Nqso (Right to Buy) | 3,266 | $329.59 | $1.08M |
| Grant/Award | Common Stock | 500 | $0.00 | $0.00 |
Holdings After Transaction:
Nqso (Right to Buy) — 3,266 contracts (Direct);
Common Stock — 8,487 shares (Direct)
Footnotes (3)
- F1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- F2. These shares include 69 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- F3. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Key Figures
Tax-withholding shares: 79 shares
Tax-withholding price: $329.59/share
Post-transaction holdings: 8,487 shares
+5 more
8 metrics
Tax-withholding shares
79 shares
Shares withheld at $329.59 on May 6, 2026
Tax-withholding price
$329.59/share
Price for 79 withheld shares on May 6, 2026
Post-transaction holdings
8,487 shares
Direct Amgen common stock after reported transactions
Stock award
500 shares
Common stock grant on May 5, 2026 at $0.00
Option grant size
3,266 options
Non-qualified stock options granted May 5, 2026
Option exercise price
$329.59/share
Exercise price for 3,266 non-qualified stock options
Option expiration
May 5, 2036
Expiration date of non-qualified stock options
Vesting schedule start
May 5, 2027
RSUs and options vest 25% annually from this date
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), non-qualified stock options, Equity Incentive Plan
4 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 69 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan"
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Amgen (AMGN) SVP Rachna Khosla report on this Form 4?
Amgen SVP Rachna Khosla reported routine equity compensation activity, including a grant of 500 shares of common stock, 3,266 non-qualified stock options, and 79 shares withheld to cover taxes. All transactions relate to Amgen’s equity incentive compensation program.
What equity awards did Amgen (AMGN) grant to Rachna Khosla in this filing?
Amgen granted Rachna Khosla 500 shares of common stock and 3,266 non-qualified stock options with a $329.59 exercise price. The awards were issued under Amgen’s Equity Incentive Plan as part of her ongoing compensation.
What are the vesting terms for Rachna Khosla’s Amgen (AMGN) RSUs and options?
The Restricted Stock Units and related non-qualified stock options vest in four equal annual installments of 25% each, starting May 5, 2027. Vested RSUs are settled in Amgen common stock on a one-to-one basis according to this schedule.
AI-generated analysis. How Rhea-AI works. Not financial advice.
